Cyteir Therapeutics, Inc. (CYT) Social Stream
CYTEIR THERAPEUTICS INC (CYT) Price Targets From Analysts
Use the tables below to see what analysts covering CYTEIR THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-19 | 4 | $40 | $23 | $31.5 | $3.05 | 932.79% |
| 2022-01-31 | 5 | $40 | $14 | $26.75 | $3.05 | 777.05% |
| 2022-02-07 | 5 | $40 | $14 | $24.6 | $3.05 | 706.56% |
| 2022-03-17 | 5 | $30 | $14 | $20.6 | $3.05 | 575.41% |
| 2022-04-26 | 5 | $30 | $14 | $19.8 | $3.05 | 549.18% |
| 2022-05-06 | 5 | $20 | $14 | $17.2 | $3.05 | 463.93% |
| 2022-05-10 | 5 | $19 | $14 | $16.6 | $3.05 | 444.26% |
| 2022-06-17 | 3 | $17 | $5 | $13.25 | $3.05 | 334.43% |
| 2022-08-08 | 4 | $17 | $5 | $13.25 | $3.05 | 334.43% |
| 2022-08-09 | 4 | $17 | $5 | $12.25 | $3.05 | 301.64% |
| 2022-08-13 | 4 | $14 | $5 | $10.666 | $3.05 | 249.7% |
| 2022-08-15 | 4 | $14 | $4 | $10.333 | $3.05 | 238.79% |
| 2022-09-17 | 4 | $13 | $4 | $7 | $3.05 | 129.51% |
| 2022-11-11 | 4 | $8 | $4 | $5.333 | $3.05 | 74.85% |
| 2023-01-27 | 4 | $4 | $3 | $3.666 | $3.05 | 20.2% |
| 2023-01-30 | 4 | $4 | $2 | $3 | $3.05 | -1.64% |
| 2023-06-06 | 4 | $3 | $2 | $2.333 | $3.05 | -23.51% |
| 2023-06-12 | 3 | $3 | $2 | $2.5 | $3.05 | -18.03% |
| 2023-08-08 | 2 | $3 | $2 | $2.5 | $3.05 | -18.03% |
The Trend in the Analyst Price Target
CYT's average price target has moved down $29 over the prior 21 months.
CYT reports an average of 37.25% for its upside potential over the past 29 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-20 | 4 | 4 | 3 | 3.666 | 1.63 | 124.91% |
| 2023-06-12 | 2 | 3 | 2 | 2.666 | 2.11 | 26.35% |
| 2023-06-12 | 1 | 3 | 2 | 2.500 | 2.11 | 18.48% |
| 2023-06-12 | 4 | 3 | 2 | 2.666 | 2.11 | 26.35% |
| 2023-06-12 | 1 | 3 | 3 | 3.000 | 2.11 | 42.18% |
CYT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.35 | 0 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
CYT's average broker recommendation rating worsened by 2 over the prior 48 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how CYTEIR THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1601.14% of that group.
- To contextualize these metrics, consider that out of all US stocks, CYTEIR THERAPEUTICS INC's number of analysts covering the stock is greater than 320.01% of them.
- CYTEIR THERAPEUTICS INC's average analyst price target is higher than 332.71% of all US stocks.
- CYTEIR THERAPEUTICS INC's variance in analysts' estimates is lower than -1407.28% of stocks in the small market cap category.
In the Pharmaceutical Products industry, GHRS, AVTE, and RLYB are the three stocks most similar to CYTEIR THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is CYT a Buy, Hold or Sell? See the POWR Ratings now!